Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Interim Management Statement

3 Nov 2009 07:00

3 November 2009 LMS Capital plc Interim Management Statement

LMS Capital plc ("LMS Capital" or "the Company") presents its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement relates to the period from 1 July 2009 to 31 October 2009.

LMS Capital is an international investment company which aims to produce high rates of return though a risk diversified portfolio. This diversification is achieved through geographical spread, primarily the US and UK, and through investment in assets of varying maturities. The major focus is in small to medium sized companies in our preferred sectors of energy services, applied technology, media & consumer, medical & healthcare and real estate.

Despite a strong performance in major stock markets, unemployment in the western economies has continued to rise and the available liquidity has been predominantly a function of governments' monetary intervention. Whilst equity markets have shown short term gains, we believe there has been little evidence of a sustained recovery. The volume of private equity and real estate transactions remains low. For the immediate future we remain cautious.

The unaudited net asset value per share at 30 September 2009 was 87 pence, an increase of 5% since 30 June 2009 and a decrease of 2% from 31 December 2008. The principal factor in this increase was the recovery in the public markets. During October we have however seen a weakening in the share prices of our two largest quoted investments, ProStrakan Group and Weatherford International, and this, coupled with a slight strengthening of the US dollar over the same period, means that we estimate that NAV per share at the end of October had fallen back to its end of June level of 83 pence.

During the three months ended 30 September 2009 funds invested by the Company were 10.5 million in unquoted securities and to meet fund calls. Proceeds from realisations of quoted securities and fund distributions were 6.5 million.

The Company's investment portfolio at 30 September 2009 was as follows:

US UK Total GBP'000 % GBP'000 % GBP'000 % Quoted 39,539 18% 23,730 11% 63,269 29% Unquoted 16,275 7% 38,785 18% 55,060 25% Funds 72,248 33% 29,133 13% 101,381 46% Total 128,062 58% 91,648 42% 219,710 100%

The carrying value of the portfolio at 30 September 2009 is based on the valuation of the Company's investment portfolio as at 30 June 2009 with adjustments for transactions in the three months ended 30 September 2009 including price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds and purchases and sales of quoted securities. In addition, where the Company has invested further amounts in its existing unquoted portfolio, such amounts have been written off as fair value adjustments in the period and investments in new unquoted securities in the period are included at cost. The next full valuation of the portfolio will be as at 31 December 2009.

The ten largest holdings at 30 September 2009 (excluding fund interests where the Company has only a minority position) were as follows:

Name Geography Type Book value % of net assets GBP'000 Weatherford US Quoted 26,415 11% International Oilfield services Prostrakan Group plc UK Quoted 21,650 9% Specialty pharmaceuticals Method Products US Fund portfolio 10,963 8% Consumer products company Rave Reviews Cinemas US Unquoted 6,210 3% Cinema operations Updata Infrastructure UK Unquoted 6,200 3% UK Wide area networks Kizoom Transport UK Unquoted 6,000 3% information systems Wesupply B2B UK Unquoted 5,500 2% connectivity software Penguin Computing US Fund portfolio 5,345 2% Linux server systems company Gulfmark Offshore US Quoted 5,084 2% Offshore services Yes To Consumer US Fund portfolio 3,857 2% products company 97,224 45%

At 30 September 2009 the Company had uncalled commitments to funds of 62.6 million which we expect to be called over the next five years. Cash and other liquid assets (including the value of our quoted portfolio) were 84.7 million. The Company has no debt.

Portfolio subsidiaries

The latest available trading results for our portfolio subsidiaries are to 30 September and these indicate that 2009 continues to produce mixed results. Updata, in which we acquired our interest in July this year, has performed well and its results to September are ahead of budget. Entuity, our network management software business, is also trading ahead of budget with significantly improved profitability. Kizoom and Coppereye have encountered difficult trading conditions in 2009 and their results for the period have been disappointing. Members of our investment team are working closely with the management of these companies to achieve improvements in their operating performance.

This statement is a general description of the financial position and performance of the Company for the period from 1 July 2009 to 31 October 2009. It does not contain any profit forecast or forward looking information. Future performance and share price is likely to be affected by a number of factors, including (but not limited to) general economic and market conditions and specific factors affecting the financial performance or prospects of individual investments within the Company's portfolio.

vendor
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.